A detailed history of Neos Investment Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Neos Investment Management LLC holds 15,614 shares of EXAS stock, worth $907,329. This represents 0.03% of its overall portfolio holdings.

Number of Shares
15,614
Previous 20,742 24.72%
Holding current value
$907,329
Previous $876 Million 21.37%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.43 - $70.83 $217,581 - $363,216
-5,128 Reduced 24.72%
15,614 $1.06 Billion
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $498,646 - $895,946
12,065 Added 139.05%
20,742 $876 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $243,142 - $318,760
4,321 Added 99.2%
8,677 $599 Million
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $257,265 - $329,836
4,356 New
4,356 $322 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.